SEC Form D · filed December 27, 2022
NextPoint Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (16)
Paulina Hill · Cambridge, MADirectorPaul Conrad · Cambridge, MAExecRakhshita Dhar · Cambridge, MADirectorDetlev Biniszkiewicz · Cambridge, MAExec · DirectorDental Innovation Alliance Management Company, LP · Cary, NCExec · DirectorDouglas W. Brown · Cary, NCExecThomas A. Sharpe · Cary, NCDirectorRenan Ugalde Amezcua · RALEIGH, NCDirectorMatthew Roden · Cambridge, MADirectorAnsbert Gadicke · CAMBRIDGE, MADirectorBonBillo Ventures Manager II LLC · North Easton, MADirectorJan Hermesdorf · Luxembourg, LuxembourgExec · DirectorSteven J. Greenblatt · New York, NYExecThomas O'Neill · Somerset, NJDirectorMatthew Roden · Cambridge, MADirectorAnsbert Gadicke · New Brighton, MNDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗